1-4 of 4
Fátima Ibáñez
Close
Sort by
Journal Articles

A Phase II Randomized Multi-Center Study to Evaluate the Safety and Efficacy of Infusion of Memory T Cells As Adoptive Therapy in Coronavirus Pneumonia and/or Lymphopenia (RELEASE NCT04578210)

Antonio Perez, Cristina Ferreras, Clara Hernandez, Alejandro Martín-Quirós, Karima Al-Akioui, Marta Mora-Rillo, Fátima Ibáñez, Rosa Goterris, Raquel De Paz Arias, Pilar Guerra-García, Javier Queiruga-Parada, Pablo Molina, Merche Bou, Carmen Mestre-Durán, Alberto Borobia, Antonio J. Carcas, María Luisa Briones, Jose Luis Vicario, Miguel Ángel Moreno, Antonio Balas, Cristina Eguizábal, Bernat Soria, Carlos Solano
Journal: Blood
Blood (2022) 140 (Supplement 1): 4570–4572.
https://doi.org/10.1182/blood-2022-166214
Published: 2022
Journal Articles

Long Term Survival Analysis of Multiple Myeloma Patients Receiving Induction Therapy+ Autologous STEM CELL Trasplantation, Comparing Velcade-Dexametasone to Alkylating Polichemotherapy As Induction Therapy

Sara Caceres, MD, Rocio Cardesa, MD, Carmen Cabrera, M. Helena Bañas, MD, Fatima Ibañez, MD, Julio Prieto, MD, Jorge Groiss, MD, Damian Toran, Carmen Hernandez, Ortegon Sergio, Duvos Elena, MD, Maria Soledad Casado, MD, Esperanza Cerezo, Raul Siguenza, Sara Suarez-Varela, Fernando Carnicero, Maria Luisa Martin Mateos, Maria J. Arcos, Angel Rodriguez, Baldomero Moriano, Ignacio Casas, Francisco Perez Leal, MD, Teresa Vazquez Godoy, Jose M. Bagace, Miguel A. Sanz, MD, Juan Miguel Miguel Bergua Burgues
Journal: Blood
Blood (2018) 132 (Supplement 1): 5764.
https://doi.org/10.1182/blood-2018-99-116924
Published: 2018
Journal Articles

NCCN-IPI in Patients with Diffuse Large B CELL Lymphoma Treated with DA-R-EPOCH. Retrospective Analysis

Juan Miguel Bergua Burgues, Luis Lopez-Gomez, MD PhD, Fatima Ibañez, MD, Sara Suarez-Varela, MD, Julio Prieto-Fernandez, Fernando Carnicero, Ignacio Casas, MD, Maria Luisa Martín-Mateos, Carmen Cabrera, María José Arcos-Carmona, MD, M Helena Bañas, MD, Nuria Bermejo, MD, Miguel A. Sanz, MD PhD, Sara Bobillo-Varela, MD, Andres Lopez
Journal: Blood
Blood (2016) 128 (22): 5401.
https://doi.org/10.1182/blood.V128.22.5401.5401
Published: 2016
Journal Articles

The Molecular Response at 3 Months, Measured Using a Genxpert Platform, Predicts Further Outcomes in Chronic Myeloid Patients, but the Cutoff Differs from the 10% Cutoff Commonly Used with the EUTOS Method

Valentín García Gutiérrez, María Teresa Gómez-Casares, Jose Manuel Puerta, Juan Manuel Alonso, Santiago Osorio, Juan Carlos Hernández-Boluda, Rosa Collado, Maria Jose Ramirez, MD, Fatima Ibañez, MD, Maria Luisa Martin, Juan Diego Rodriguez, Carolina Martinez-Laperche, Montse Gomez, Viviana Fiallo, Redondo Sara, Alicia Rodriguez, Concepcion Ruiz, Juan Luis Steegmann, MD, Antonio Jiménez-Velasco, MD
Journal: Blood
Blood (2016) 128 (22): 1906.
https://doi.org/10.1182/blood.V128.22.1906.1906
Published: 2016